K Number
K251847

Validate with FDA (Live)

Date Cleared
2026-01-15

(213 days)

Product Code
Regulation Number
868.5905
Age Range
18 - 120
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticPediatricDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Sleepnet Arie Full Face Vented Mask is intended to be used with positive airway pressure devices, such as CPAP or bi-level, operating at or above 4 cm H2O. The mask is to be used on adult patients (>30kg) for whom positive airway pressure therapy has been prescribed. The mask is intended for single-patient multi-use in the home, hospital, or institutional environment.

The Sleepnet Arie Nasal Vented Mask is intended to be used with positive airway pressure devices, such as CPAP or bi-level, operating at or above 4 cm H2O. The mask is to be used on adult patients (>30kg) for whom positive airway pressure therapy has been prescribed. The mask is intended for single-patient multi-use in the home, hospital, or institutional environment.

Device Description

The Sleepnet Arie Full Face Vented and Nasal Mask are designed based on the human facial shape, and the operating characteristics during application. The Sleepnet mask utilizes a Liquid Silicone Rubber (LSR) cushion design. The device is composed of medical-grade injection molded thermoplastics & clear liquid silicone rubber. The device is used as the interface between a CPAP/BiPAP machine and the end user. The masks are held in place with adjustable headgear that straps the mask to the face.

The Arie Full Mask is accompanied by a vented frame/tubing assembly which includes the Arie Full Face Vented Mask Headgear connector, valve, swivel ball, tubing, swivel connector assembly (swivel connector and clear swivel), and the JustFit Full Face Headgear with clips.

AI/ML Overview

N/A

FDA 510(k) Clearance Letter - Sleepnet Arie Masks

Page 1

U.S. Food & Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
www.fda.gov

Doc ID # 04017.08.02

January 15, 2026

Sleepnet Corporation
℅ Todd Courtney
Vice President, Anesthesia, Respiratory, Sleep, and ENT Regulatory Affairs
Mcra, LLC
803 7th Street, NW
3rd Floor
Washington, District of Columbia 20001

Re: K251847
Trade/Device Name: Sleepnet Arie Full Face Vented Mask; Sleepnet Arie Nasal Vented Mask
Regulation Number: 21 CFR 868.5905
Regulation Name: Noncontinuous Ventilator (IPPB)
Regulatory Class: Class II
Product Code: BZD
Dated: December 11, 2025
Received: December 15, 2025

Dear Todd Courtney:

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Page 2

K251847 - Todd Courtney Page 2

Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).

Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.

All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-

Page 3

K251847 - Todd Courtney Page 3

assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Binoy J. Mathews -S Digitally signed by Binoy J. Mathews -S Date: 2026.01.15 11:23:52 -05'00'

For

Rachana Visaria
Assistant Director
DHT1C: Division of Anesthesia, Respiratory, and Sleep Devices
OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health

Enclosure

Page 4

FORM FDA 3881 (8/23) Page 1 of 1 PSC Publishing Services (301) 443-6740 EF

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Indications for Use

Form Approved: OMB No. 0910-0120
Expiration Date: 07/31/2026
See PRA Statement below.

510(k) Number (if known): K251847

Device Name: Sleepnet Arie Full Face Vented Mask; Sleepnet Arie Nasal Vented Mask

Indications for Use (Describe)

The Sleepnet Arie Full Face Vented Mask is intended to be used with positive airway pressure devices, such as CPAP or bi-level, operating at or above 4 cm H2O. The mask is to be used on adult patients (>30kg) for whom positive airway pressure therapy has been prescribed. The mask is intended for single-patient multi-use in the home, hospital, or institutional environment.

The Sleepnet Arie Nasal Vented Mask is intended to be used with positive airway pressure devices, such as CPAP or bi-level, operating at or above 4 cm H2O. The mask is to be used on adult patients (>30kg) for whom positive airway pressure therapy has been prescribed. The mask is intended for single-patient multi-use in the home, hospital, or institutional environment.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

Page 5

510(k) Summary

Device Trade Name: Arie Full Face Vented Mask and Arie Nasal Vented Mask

Manufacturer: Sleepnet Corporation
5 Merrill Industrial Drive
Hampton, NH 03842

Contact: Todd Courtney
Vice President, Anesthesia, Respiratory, Sleep, and ENT Regulatory Affairs
MCRA, LLC
Office: (202) 552-5800

Prepared by: MCRA, LLC
803 7th Street, NW, 3rd Floor
Washington, DC 20001
Office: 202.552.5800

Date Prepared: January 15, 2026

Classifications: 21 CFR 868.5905; Noncontinuous ventilator (IPPB)

Class: II

Product Codes: BZD

510(k) Number: K251847

Primary Predicate: AirFit F20 Full Face Mask, K153563 (for Arie Full Face Vented Mask)
AirFit N20 Nasal Mask, K171212 (for Arie Nasal Vented Mask)

Reference Device: F&P Evora Full Face Mask, K212371 (for Arie Full Face Vented Mask only)

Indications For Use:

Arie Full Face Vented Mask

The Sleepnet Arie Full Face Vented Mask is intended to be used with positive airway pressure devices, such as CPAP or bi-level, operating at or above 4 cm H2O. The mask is to be used on adult patients (>30kg) for whom positive airway pressure therapy has been prescribed. The mask is intended for single-patient multi-use in the home, hospital, or institutional environment.

Page 6

Arie Nasal Vented Mask

The Sleepnet Arie Nasal Vented Mask is intended to be used with positive airway pressure devices, such as CPAP or bi-level, operating at or above 4 cm H2O. The mask is to be used on adult patients (>30kg) for whom positive airway pressure therapy has been prescribed. The mask is intended for single-patient multi-use in the home, hospital, or institutional environment.

Device Description:

The Sleepnet Arie Full Face Vented and Nasal Mask are designed based on the human facial shape, and the operating characteristics during application. The Sleepnet mask utilizes a Liquid Silicone Rubber (LSR) cushion design. The device is composed of medical-grade injection molded thermoplastics & clear liquid silicone rubber. The device is used as the interface between a CPAP/BiPAP machine and the end user. The masks are held in place with adjustable headgear that straps the mask to the face.

The Arie Full Mask is accompanied by a vented frame/tubing assembly which includes the Arie Full Face Vented Mask Headgear connector, valve, swivel ball, tubing, swivel connector assembly (swivel connector and clear swivel), and the JustFit Full Face Headgear with clips.

Predicate Device:

Sleepnet submits the following information in this Premarket Notification to demonstrate that, for the purposes of FDA's regulation of medical devices, Arie Full Face Vented and Nasal Vented Mask is substantially equivalent in indications, design principles, and performance to the following predicate devices, which have been determined by FDA to be substantially equivalent to pre-amendment devices:

Primary Predicate: AirFit F20 Full Face Mask, K153563 (for Arie Full Face Vented Mask)
AirFit N20 Nasal Mask, K171212 (for Arie Nasal Vented Mask)

Reference Device: F&P Evora Full Face Mask, K212371 (for Arie Full Face Vented Mask only)

Performance Testing Summary:

The following tests have been performed on the Arie Full Face Vented and Nasal Vented Masks:

  • CO2 Rebreathing
  • Exhaust Flow Test
  • Pressure Drop Test
  • Dead Space Measurement
  • Anti-Asphyxia Valve Pressure Test
  • Anti-Asphyxia Valve Breathing in Resistance Test
  • Anti-Asphyxia Valve Life Test
  • Sound Test

Page 7

Tests were conducted according to recognized standards:

  • ISO 17510: Medical devices — Sleep apnoea breathing therapy — Masks and application accessories
  • ISO 3744: Acoustics — Determination of sound power levels and sound energy levels of noise sources using sound pressure — Engineering methods for an essentially free field over a reflecting plane
  • ISO 5356: Anaesthetic and respiratory equipment — Conical connectors — Part 1: Cones and sockets
  • IEC 60068-2-31: Environmental testing — Part 2-31: Tests — Test Ec: Rough handling shocks, primarily for equipment-type specimens
  • ISO 17664: Processing of health care products — Information to be provided by the medical device manufacturer for the processing of medical devices
  • ISO 10993-1: Biological evaluation of medical devices. Part 1: Requirements and general principles for the evaluation of biological safety within a risk management process
  • ISO 10993-5: Biological evaluation of medical devices. Part 5: Tests for in vitro cytotoxicity
  • ISO 10993-10: Biological evaluation of medical devices. Part 10: Tests for skin sensitization
  • ISO 10993-12: Biological evaluation of medical devices. Part 12: Sample preparation and reference materials
  • ISO 10993-18:2020/Amd1:2022: Biological evaluation of medical devices. Part 18: Chemical characterization of medical device materials within a risk management process
  • ISO 10993-23: Biological evaluation of medical devices. Part 23: Tests for irritation
  • ISO 18562-1:2017: Biocompatibility evaluation of breathing gas pathways in healthcare applications. Part 1: Evaluation and testing within a risk management process
  • ISO 18562-2: Biocompatibility evaluation of breathing gas pathways in healthcare applications. Part 2: Tests for emissions of particulate matter
  • ISO18562-3: Biocompatibility evaluation of breathing gas pathways in healthcare applications. Part 3: Tests for emissions of volatile organic substances

Substantial Equivalence:

The Arie Full Face Vented and Nasal Vented Masks are substantially equivalent to AirFit F20 Full Face Mask (K153563) and AirFit N20 Nasal Mask (K171212) with respect to intended use, patient population, exhaust flow, AAV pressure, pressure drop, and therapy pressure range.

Page 8

Table 1: Substantial Equivalence - Arie Full Face Vented Mask

Subject DevicePrimary PredicateReference Device
Device NameArie Full Face Vented Vented MaskResmed AirFit F20 Full Face Mask
CompanySleepnet CorporationResmed Ltd
510(k) NumberK251847K153563
Classification21 CFR 868.590521 CFR 868.5905
Product CodeBZDBZD
Common/Usual NameCPAP/BiPAP MaskFull Face Mask
Principle of OperationSeal over the nose and mouth to allow delivery of pressurized air from a PAP device. Interface for CPAP device or Bilevel/Auto-PAP devicesInterface for CPAP device or Bilevel/Auto-PAP devices
Patient Use TypeAdult Subjects >30kgAdult Subjects >30kg
Indications for UseArie Full Face Vented Mask is intended to be used with positive airway pressure devices, such as CPAP or bi-level, operating at or above 4 cm H2O. The mask is to be used on adult patients (>30kg) for whom positive airway pressure therapy has been prescribed. The mask is intended for single-patient multi-use in the home, hospital, or institutional environment.The AirFit F20 is a non-invasive accessory used for channeling airflow (with or without supplemental oxygen) to a patient from a positive airway pressure (PAP) device such as a continuous positive airway pressure (CPAP) or bilevel system. The AirFit F20 is: • to be used by patients weighing more than 66 lb (30 kg) for whom positive airway pressure therapy has been prescribed • intended for single-patient reuse in the home environment and multi-patient reuse in the hospital/institutional environment.
EnvironmentHome, hospital or institutional environmentHome, hospital or institutional environment

Page 9

Subject DevicePrimary PredicateReference DeviceComparison to Primary Predicate
Operating and Storage ConditionsOperating Temperature: 5°C to 40°C Storage Temperature: -20°C to 60°CNot Publicly AvailableOperating Temperature: 5°C to 40°C Storage Temperature: -20°C to 50°C
ReuseSingle patient, multi-useSingle patient, Multi-Use Multiple patient useSingle patient, Multi-Use Multiple patient use
Useful Life12 monthsNot Publicly Available24 months
Anatomical siteFace (seals around the nose and mouth)Face (seals around the nose and mouth)Face (seals around the nose and mouth)
Mask SizeThree sizes available – Small, Medium, LargeOffered in various sizesThree sizes available – Extra Small, Small-Medium, Large
Mask WeightSmall – 68 grams Medium – 75 grams Large – 85 gramsNot Publicly AvailableNot Publicly Available
Exhaust flow characteristicsPressure (cm H2O) Flow (lpm) 4 28.5 10 39.1 20 54.9 30 67.2 40 81.2Not Publicly AvailableNot Publicly Available
Mask Dead SpaceSmall: 140 mL Medium: 225 mL Large: 240 mLNot Publicly AvailableXS: 165.2 cm³ S-M: 162.6 cm³ L: 164.1 cm³

Page 10

Subject DevicePrimary PredicateReference DeviceComparison to Primary Predicate
Sound Power Level• A-weighted Sound Power Level: 32.1 dBA • A-weighted Sound Pressure Level at 1m distance: 24.1 dBANot Publicly Available• A-weighted Sound Power Level of the Mask: 28.2 dBA, with uncertainty 2.5 dBA • Sound Pressure Level of the Mask: 20.2 dBA, with uncertainty 2.5 dBA
AAV pressure• AAV opening pressure: 1.16 cm H2O • AAV closing pressure: 1.82 cm H2ONot Publicly AvailableNot Publicly Available
SterilityProvided Non-SterileProvided Non-SterileProvided Non-Sterile
Validated Cleaning (Single-Patient Use)Mild soap and warm water.Not Publicly AvailableNot Publicly Available
Validated DisinfectionN/ANot Publicly AvailableThermal Disinfection: 90°C for 1 min

Page 11

Subject DevicePrimary PredicateReference DeviceComparison to Primary Predicate
Therapy Pressure Range4 to 40 cm H2O.Not Publicly Available4 to 30 cmH2O
Resistance to Flow (Pressure drop)• Pressure drop at 50 L/min: 1.05 cm H2O • Pressure drop at 100 L/min: 3.09 cm H2ONot Publicly Available• Pressure drop at 50 L/min: 0.9 ± 0.3 cm H2O • Pressure drop at 100 L/min: 2.2 ± 0.3cm H2O
MaterialsPolycarbonate, Liquid Silicone Rubber, Polypropylene, TPENot Publicly AvailableNot Publicly Available
CO2 RebreathingCondition ETCO2: Percentage Relative Increase over Baseline Normal: 4 cm H2O 16% 5 cm H2O 14% 10 cm H2O 12% Single Fault: SF1 – Open end 35% SF2 - Occluded 36%Not Publicly AvailableNot Publicly Available

Page 12

Table 2: Substantial Equivalence - Arie Nasal Vented Mask

Subject DeviceProposed PredicateComparison
Device NameArie nasal vented maskAirFit N20 Nasal Mask
CompanySleepnet CorporationResmed Ltd
510(k) NumberK251847K171212
Classification21 CFR 868.590521 CFR 868.5905
Product CodeBZDBZD
Common/Usual NameCPAP/BiPAP MaskVented Nasal Mask
Principle of OperationSeal over the nose to allow delivery of pressurized air from a PAP device. Interface for CPAP or Bi-level/Auto-PAP devicesSeal over the nose to allow delivery of pressurized air from a PAP device. Interface for CPAP or Bi-level/Auto-PAP devices
Patient Use TypeAdult Subjects >30kgAdult Subjects >30kg
Indications for UseArie Nasal Vented Mask is intended to be used with positive airway pressure devices, such as CPAP or bi-level, operating at or above 4 cm H2O. The mask is to be used on adult patients (>30kg) for whom positive airway pressure therapy has been prescribed. The mask is intended for single-patient multi-use in the home, hospital, or institutional environment.The AirFit N20 channels airflow noninvasively to a patient from a positive airway pressure (PAP) device such as a continuous positive airway pressure (CPAP) or bilevel device. The AirFit N20 is: • to be used by patients weighing more than 66 lb (30 kg) for whom positive airway pressure has been prescribed • intended for single patient re-use in the home environment and multi-patient re-use in the hospital / institutional environment
EnvironmentHome, hospital or institutional environmentHome, hospital or institutional environment
Operating and Storage ConditionsOperating Temperature: 5°C to 40°C Storage Temperature: -20°C to 60°CNot Publicly Available

Page 13

Subject DeviceProposed PredicateComparison
ReuseSingle patient, multi-use• Single patient, Multi-Use • Multiple patient use
Useful Life12 monthsNot Publicly Available
Anatomical siteFace (seals around the nose)Face (seals around the nose)
Mask SizeThree size available – Small, Medium, LargeOffered in various sizes
Mask WeightSmall – 41 grams Medium – 44 grams Large – 46 gramsNot Publicly Available
Exhaust flow characteristicsPressure (cm H2O) Flow (lpm) 4 23.0 10 35.9 20 50.5 30 63.8Not Publicly Available
Mask Dead SpaceSmall: 60 mL Medium: 75 mL Large: 95 mLNot Publicly Available
Sound Power LevelA-weighted sound power level: 28.4 dBA. A-weighted sound pressure level at 1m distance: 20.4 dBA.Not Publicly Available
SterilityProvided Non-SterileProvided Non-Sterile
Validated Cleaning (Single-Patient Use)Mild soap and warm water;Not Publicly Available
Validated DisinfectionN/ANot Publicly Available
Therapy Pressure Range4 to 30 cm H2O.Not Publicly Available

Page 14

Subject DeviceProposed PredicateComparison
Resistance to Flow (Pressure drop)• Pressure drop at 50 L/min: 0.43 cm H2O • Pressure drop at 100 L/min: 1.98 cm H2ONot Publicly Available
MaterialsPolycarbonate, Liquid Silicone Rubber, Polypropylene, TPENot Publicly Available
CO2 RebreathingCondition ETCO2: Percentage Relative Increase over Baseline Normal: 4 cm H2O 17% 5 cm H2O 11% 10 cm H2O 3%Not Publicly Available

Page 15

Conclusion:

The subject device and the predicate devices have the same intended use, have similar technological characteristics, and are made of similar materials. The subject and predicate devices are packaged in similar materials and are sterilized using similar methods. The data included in this submission demonstrate substantial equivalence to the predicate devices listed above.

§ 868.5905 Noncontinuous ventilator (IPPB).

(a)
Identification. A noncontinuous ventilator (intermittent positive pressure breathing-IPPB) is a device intended to deliver intermittently an aerosol to a patient's lungs or to assist a patient's breathing.(b)
Classification. Class II (performance standards).